{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T18:14:01Z","timestamp":1758824041791},"reference-count":58,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,5,1]],"date-time":"2012-05-01T00:00:00Z","timestamp":1335830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Immunology and Allergy Clinics of North America"],"published-print":{"date-parts":[[2012,5]]},"DOI":"10.1016\/j.iac.2012.04.010","type":"journal-article","created":{"date-parts":[[2012,4,19]],"date-time":"2012-04-19T07:20:12Z","timestamp":1334820012000},"page":"309-315","source":"Crossref","is-referenced-by-count":11,"title":["Mycophenolate Mofetil for the Management of Autoimmune Bullous Diseases"],"prefix":"10.1016","volume":"32","author":[{"given":"Marina","family":"Eskin-Schwartz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"David","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Mimouni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl 1","key":"10.1016\/j.iac.2012.04.010_bib1","doi-asserted-by":"crossref","first-page":"s2","DOI":"10.1177\/096120330501400102","article-title":"Mechanisms of action of mycophenolate mofetil","volume":"14","author":"Allison","year":"2005","journal-title":"Lupus"},{"key":"10.1016\/j.iac.2012.04.010_bib2","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1600-065X.1993.tb00652.x","article-title":"Immunosuppressive and other effects of mycophenolic acid and an ester prodrug, mycophenolate mofetil","volume":"136","author":"Allison","year":"1993","journal-title":"Immunol Rev"},{"key":"10.1016\/j.iac.2012.04.010_bib3","doi-asserted-by":"crossref","first-page":"27286","DOI":"10.1016\/S0021-9258(19)74247-1","article-title":"Characterization of human type I and type II IMP dehydrogenases","volume":"268","author":"Carr","year":"1993","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.iac.2012.04.010_bib4","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0162-3109(00)00188-0","article-title":"Mycophenolate mofetil and its mechanisms of action","volume":"47","author":"Allison","year":"2000","journal-title":"Immunopharmacology"},{"key":"10.1016\/j.iac.2012.04.010_bib5","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1097\/00007890-199908150-00014","article-title":"Mycophenolic acid increases apoptosis, lysosomes and lipid droplets in human lymphoid and monocytic cell lines","volume":"68","author":"Cohn","year":"1999","journal-title":"Transplantation"},{"key":"10.1016\/j.iac.2012.04.010_bib6","first-page":"10","article-title":"In\u00a0vitro immunosuppressive effects of mycophenolic acid and an ester pro-drug, RS-61443","volume":"23","author":"Allison","year":"1991","journal-title":"Transplant Proc"},{"key":"10.1016\/j.iac.2012.04.010_bib7","first-page":"67","article-title":"Mycophenolic acid and brequinar, inhibitors of purine and pyrimidine synthesis, block the glycosylation of adhesion molecules","volume":"25","author":"Allison","year":"1993","journal-title":"Transplant Proc"},{"key":"10.1016\/j.iac.2012.04.010_bib8","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1016\/S0041-1345(98)01984-8","article-title":"Mycophenolate mofetil impairs transendothelial migration of allogeneic CD4 and CD8 T-cells","volume":"31","author":"Blaheta","year":"1999","journal-title":"Transplant Proc"},{"issue":"Suppl 17","key":"10.1016\/j.iac.2012.04.010_bib9","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1399-0012.2006.00597.x","article-title":"Antifibrotic actions of mycophenolic acid","volume":"20","author":"Morath","year":"2006","journal-title":"Clin Transplant"},{"key":"10.1016\/j.iac.2012.04.010_bib10","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1046\/j.1365-2249.2003.02269.x","article-title":"Mycophenolate mofetil inhibits differentiation, maturation and allostimulatory function of human monocyte-derived dendritic cells","volume":"134","author":"Colic","year":"2003","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.iac.2012.04.010_bib11","doi-asserted-by":"crossref","first-page":"37S","DOI":"10.1097\/01.TP.0000067950.90241.1D","article-title":"Effects of immunosuppressive drugs on dendritic cells and tolerance induction","volume":"75","author":"Lagaraine","year":"2003","journal-title":"Transplantation"},{"key":"10.1016\/j.iac.2012.04.010_bib12","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1097\/00007890-199511270-00015","article-title":"Mycophenolic acid, an inhibitor of IMP dehydrogenase that is also an immunosuppressive agent, suppresses the cytokine-induced nitric oxide production in mouse and rat vascular endothelial cells","volume":"60","author":"Senda","year":"1995","journal-title":"Transplantation"},{"key":"10.1016\/j.iac.2012.04.010_bib13","doi-asserted-by":"crossref","first-page":"429","DOI":"10.2165\/00003088-199834060-00002","article-title":"Clinical pharmacokinetics of mycophenolate mofetil","volume":"34","author":"Bullingham","year":"1998","journal-title":"Clin Pharm"},{"issue":"Suppl","key":"10.1016\/j.iac.2012.04.010_bib14","first-page":"85","article-title":"Mycophenolic acid and its mechanism of action in cancer and psoriasis","volume":"30","author":"Sweeney","year":"1977","journal-title":"Jpn J Antibiot"},{"key":"10.1016\/j.iac.2012.04.010_bib15","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/j.1552-4604.1996.tb04207.x","article-title":"Pharmacokinetics and bioavailability of mycophenolate mofetil in healthy subjects after single-dose oral and intravenous administration","volume":"36","author":"Bullingham","year":"1996","journal-title":"J\u00a0Clin Pharmacol"},{"key":"10.1016\/j.iac.2012.04.010_bib16","unstructured":"Hoffman-La Roche Ltd. Cellcept (mycophenolate mofetil); 1997 [package insert]. Available at: http:\/\/www.gene.com\/gene\/products\/information\/cellcept\/pdf\/pi.pdf. Accessed June 24, 2011."},{"key":"10.1016\/j.iac.2012.04.010_bib17","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/S0190-9622(87)70285-0","article-title":"Mycophenolic acid for psoriasis. A review of pharmacology, long-term efficacy, and safety","volume":"17","author":"Epinette","year":"1987","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.iac.2012.04.010_bib18","doi-asserted-by":"crossref","first-page":"75","DOI":"10.2165\/00002018-199717020-00001","article-title":"Preliminary risk-benefit assessment of mycophenolate mofetil in transplant rejection","volume":"17","author":"Simmons","year":"1997","journal-title":"Drug Saf"},{"key":"10.1016\/j.iac.2012.04.010_bib19","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1038\/sj.bmt.1703583","article-title":"Increased risk of complicated CMV infection with the use of mycophenolate mofetil in allogeneic stem cell transplantation","volume":"29","author":"Hambach","year":"2002","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.iac.2012.04.010_bib20","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1034\/j.1399-0012.2000.140206.x","article-title":"Mycophenolate mofetil increases cytomegalovirus invasive organ disease in renal transplant patients","volume":"14","author":"Sarmiento","year":"2000","journal-title":"Clin Transplant"},{"key":"10.1016\/j.iac.2012.04.010_bib21","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1093\/ndt\/15.5.711","article-title":"The influence of mycophenolate mofetil on the incidence and severity of primary cytomegalovirus infections and disease after renal transplantation","volume":"15","author":"ter Meulen","year":"2000","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.iac.2012.04.010_bib22","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/S0190-9622(97)70147-6","article-title":"Rediscovering mycophenolic acid: a review of its mechanism, side effects, and potential uses","volume":"37","author":"Kitchin","year":"1997","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.iac.2012.04.010_bib23","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/S0272-6386(99)70358-6","article-title":"Mycophenolate mofetil in cadaveric renal transplantation. US Renal Transplant Mycophenolate Mofetil Study Group","volume":"34","year":"1999","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.iac.2012.04.010_bib24","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1097\/00007890-199806150-00007","article-title":"A\u00a0blinded, long-term, randomized multicenter study of mycophenolate mofetil in cadaveric renal transplantation: results at three years. Tricontinental Mycophenolate Mofetil Renal Transplantation Study Group","volume":"65","author":"Mathew","year":"1998","journal-title":"Transplantation"},{"key":"10.1016\/j.iac.2012.04.010_bib25","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1097\/00007890-199908150-00011","article-title":"Mycophenolate mofetil in renal transplantation: 3-year results from the placebo-controlled trial. European Mycophenolate Mofetil Cooperative Study Group","volume":"68","year":"1999","journal-title":"Transplantation"},{"key":"10.1016\/j.iac.2012.04.010_bib26","doi-asserted-by":"crossref","first-page":"2954","DOI":"10.1111\/j.1600-6143.2005.01125.x","article-title":"Prospective registry-based observational cohort study of the long-term risk of malignancies in renal transplant patients treated with mycophenolate mofetil","volume":"5","author":"Robson","year":"2005","journal-title":"Am J Transplant"},{"key":"10.1016\/j.iac.2012.04.010_bib27","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1001\/archderm.1977.01640090051004","article-title":"Mycophenolic acid for psoriasis","volume":"113","author":"Lynch","year":"1977","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.iac.2012.04.010_bib28","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1002\/ajmg.a.32685","article-title":"Reviewing the evidence for mycophenolate mofetil as a new teratogen: case report and review of the literature","volume":"149A","author":"Anderka","year":"2009","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.iac.2012.04.010_bib29","series-title":"Comprehensive dermatologic drug therapy","first-page":"1099","article-title":"Cytotoxic agents","author":"Perlis","year":"2007"},{"key":"10.1016\/j.iac.2012.04.010_bib30","doi-asserted-by":"crossref","first-page":"685","DOI":"10.2165\/00003088-200443100-00004","article-title":"Evaluation of pharmacokinetic interactions after oral administration of mycophenolate mofetil and valaciclovir or aciclovir to healthy subjects","volume":"43","author":"Gimenez","year":"2004","journal-title":"Clin Pharm"},{"key":"10.1016\/j.iac.2012.04.010_bib31","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1111\/1523-1747.ep12610346","article-title":"Treatment of psoriasis with oral mycophenolic acid","volume":"65","author":"Jones","year":"1975","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.iac.2012.04.010_bib32","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/S0190-9622(79)80097-3","article-title":"Efficacy of mycophenolic acid for the treatment of psoriasis","volume":"1","author":"Gomez","year":"1979","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.iac.2012.04.010_bib33","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1001\/archderm.135.1.54","article-title":"Mycophenolate is effective in the treatment of pemphigus vulgaris","volume":"135","author":"Enk","year":"1999","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.iac.2012.04.010_bib34","first-page":"23","volume":"129","author":"Chams-Davatchi","year":"2002","journal-title":"Ann Dermatol Venereol"},{"key":"10.1016\/j.iac.2012.04.010_bib35","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1001\/archderm.139.6.739","article-title":"Treatment of pemphigus vulgaris and pemphigus foliaceus with mycophenolate mofetil","volume":"139","author":"Mimouni","year":"2003","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.iac.2012.04.010_bib36","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1046\/j.1365-2133.2003.05269.x","article-title":"An evaluation of the usefulness of mycophenolate mofetil in pemphigus","volume":"149","author":"Powell","year":"2003","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.iac.2012.04.010_bib37","first-page":"159","article-title":"Treatment of pemphigus vulgaris with mycophenolate mofetil as a steroid-sparing agent","volume":"18","author":"Esmaili","year":"2008","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.iac.2012.04.010_bib38","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1038\/jid.2010.91","article-title":"Treating pemphigus vulgaris with prednisone and mycophenolate mofetil: a multicenter, randomized, placebo-controlled trial","volume":"130","author":"Beissert","year":"2010","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.iac.2012.04.010_bib39","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/S0190-9622(99)70084-8","article-title":"Mycophenolate mofetil: a new therapeutic option in the treatment of blistering autoimmune diseases","volume":"40","author":"Grundmann-Kollmann","year":"1999","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.iac.2012.04.010_bib40","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1111\/j.1468-3083.2009.03226.x","article-title":"Efficacy and\u00a0safety of long-term mycophenolate sodium therapy in pemphigus vulgaris","volume":"23","author":"Baskan","year":"2009","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.iac.2012.04.010_bib41","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1001\/archderm.142.11.1447","article-title":"A\u00a0comparison of oral methylprednisolone plus azathioprine or mycophenolate mofetil for the treatment of pemphigus","volume":"142","author":"Beissert","year":"2006","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.iac.2012.04.010_bib42","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.jaad.2007.05.024","article-title":"Randomized controlled open-label trial of four treatment regimens for pemphigus vulgaris","volume":"57","author":"Chams-Davatchi","year":"2007","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.iac.2012.04.010_bib43","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1046\/j.1365-2133.2000.03365.x","article-title":"Use of mycophenolate mofetil in the treatment of paraneoplastic pemphigus","volume":"142","author":"Williams","year":"2000","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.iac.2012.04.010_bib44","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/S0140-6736(97)80092-X","article-title":"Bullous pemphigoid treated with mycophenolate mofetil","volume":"349","author":"Bohm","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.iac.2012.04.010_bib45","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0190-9622(98)70334-2","article-title":"Successful therapy for bullous pemphigoid with mycophenolate mofetil","volume":"39","author":"Nousari","year":"1998","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.iac.2012.04.010_bib46","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1001\/archderm.143.12.1536","article-title":"A\u00a0comparison of oral methylprednisolone plus azathioprine or mycophenolate mofetil for the treatment of bullous pemphigoid","volume":"143","author":"Beissert","year":"2007","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.iac.2012.04.010_bib47","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1067\/mjd.2001.114746","article-title":"Treatment of cicatricial pemphigoid with mycophenolate mofetil as a steroid-sparing agent","volume":"45","author":"Megahed","year":"2001","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.iac.2012.04.010_bib48","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1080\/09546630600964999","article-title":"Treatment of refractory blistering autoimmune diseases with mycophenolic acid","volume":"17","author":"Marzano","year":"2006","journal-title":"J\u00a0Dermatolog Treat"},{"key":"10.1016\/j.iac.2012.04.010_bib49","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0151-9638(05)79188-2","volume":"132","author":"Ingen-Housz-Oro","year":"2005","journal-title":"Ann Dermatol Venereol"},{"key":"10.1016\/j.iac.2012.04.010_bib50","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.ajo.2009.09.026","article-title":"Mycophenolate mofetil for ocular inflammation","volume":"149","author":"Daniel","year":"2010","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.iac.2012.04.010_bib51","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.ophtha.2007.04.027","article-title":"Immunosuppressive therapy for ocular mucous membrane pemphigoid strategies and outcomes","volume":"115","author":"Saw","year":"2008","journal-title":"Ophthalmology"},{"key":"10.1016\/j.iac.2012.04.010_bib52","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1046\/j.1365-2133.1999.03176.x","article-title":"Treatment of epidermolysis bullosa acquisita with mycophenolate mofetil and autologous keratinocyte grafting","volume":"141","author":"Schattenkirchner","year":"1999","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.iac.2012.04.010_bib53","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1159\/000073104","article-title":"Mycophenolate mofetil in epidermolysis bullosa acquisita","volume":"207","author":"Kowalzick","year":"2003","journal-title":"Dermatology"},{"key":"10.1016\/j.iac.2012.04.010_bib54","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/j.jaad.2005.07.009","article-title":"Childhood IgA-mediated epidermolysis bullosa acquisita responding to mycophenolate mofetil as a corticosteroid-sparing agent","volume":"54","author":"Tran","year":"2006","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.iac.2012.04.010_bib55","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/j.1365-2230.2005.01741.x","article-title":"Successful treatment of linear IgA disease with mycophenolate mofetil as a corticosteroid sparing agent","volume":"30","author":"Talhari","year":"2005","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.iac.2012.04.010_bib56","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.tripleo.2006.09.019","article-title":"Successful treatment of oral linear IgA disease using mycophenolate","volume":"103","author":"Lewis","year":"2007","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"10.1016\/j.iac.2012.04.010_bib57","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1080\/09546630801958246","article-title":"Refractory linear IgA bullous dermatosis successfully treated with mycophenolate sodium","volume":"19","author":"Marzano","year":"2008","journal-title":"J\u00a0Dermatolog Treat"},{"key":"10.1016\/j.iac.2012.04.010_bib58","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1001\/archderm.139.9.1121","article-title":"Treatment of linear IgA bullous dermatosis of childhood with mycophenolate mofetil","volume":"139","author":"Farley-Li","year":"2003","journal-title":"Arch Dermatol"}],"container-title":["Immunology and Allergy Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889856112000252?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889856112000252?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,1,13]],"date-time":"2022-01-13T08:32:48Z","timestamp":1642062768000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889856112000252"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5]]},"references-count":58,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,5]]}},"alternative-id":["S0889856112000252"],"URL":"https:\/\/doi.org\/10.1016\/j.iac.2012.04.010","relation":{},"ISSN":["0889-8561"],"issn-type":[{"value":"0889-8561","type":"print"}],"subject":[],"published":{"date-parts":[[2012,5]]}}}